SOURCE: ScripsAmerica


July 07, 2014 08:30 ET

ScripsAmerica's Managed Specialty Pharmacy Receives Approved Orders of $2.7 Million in June

TYSONS CORNER, VA--(Marketwired - Jul 7, 2014) - ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company's managed specialty pharmacy reported $2,706,709 in prescription approved orders during the month of June.

'Main Avenue Pharmacy,' which specializes in prescription topical pain creams, recorded an increase of 69% in approved orders from May to June, topping the 67% revenue growth during the previous month. Since ScripsAmerica entered an agreement to manage Main Avenue Pharmacy in mid-February 2014, the pharmacy's annual run rate has increased from $6 million to $32 million.

Commenting on the growth of ScripsAmerica's managed compounding pharmacy, CEO Bob Schneiderman said, "We are happy to report a sustained high growth rate for our specialty pharmacy in June and expect our monthly revenue to potentially increase again in July. The Company will continue to build on the success of Main Avenue Pharmacy moving forward as this has become a steady, significant revenue source for ScripsAmerica and its shareholders."

About ScripsAmerica, Inc.

ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit

Safe Harbor Statement

This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact Information